microRNA-29 mediates a novel negative feedback loop to regulate SCAP/SREBP-1 and lipid metabolism

Area of Science:

• Molecular Biology
• Cancer Biology
• Metabolic Disease Research

Background:

• Sterol regulatory element-binding proteins (SREBPs) regulate lipid metabolism.
• SCAP (SREBP-cleavage activating protein) is crucial for SREBP activation and is upregulated in glioblastoma (GBM).
• Glucose-mediated N-glycosylation of SCAP is essential for SCAP/SREBP trafficking.

Purpose of the Study:

• To investigate the role of microRNA-29 (miR-29) in regulating the SCAP/SREBP-1 pathway.
• To determine if miR-29 can suppress GBM tumor growth and lipid synthesis.
• To explore miR-29 as a potential therapeutic for cancer and metabolic diseases.

Main Methods:

• Investigated the feedback loop between SREBP-1 and miR-29 family members (miR-29a, -29b, -29c).
• Assessed the effect of miR-29 mimics on SCAP/SREBP-1 expression and de novo lipid synthesis in GBM.
• Evaluated GBM tumor growth in response to miR-29 mimic treatment.

Main Results:

• SREBP-1 transcriptionally upregulates miR-29 expression.
• miR-29 negatively feedbacks to repress SCAP and SREBP-1 expression.
• miR-29 mimic treatment suppressed GBM tumor growth by inhibiting SCAP/SREBP-1 and de novo lipid synthesis.

Conclusions:

• miR-29 mediates a novel negative feedback loop in SCAP/SREBP-1 signaling.
• Targeting the SCAP/SREBP-1 pathway with miR-29 offers a promising therapeutic strategy for GBM.
• miR-29 delivery may be a viable approach for treating cancers and metabolic diseases driven by aberrant lipid metabolism.